FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022361557> ?p ?o ?g. }

• W2022361557 endingPage "926" @default.
• W2022361557 startingPage "915" @default.
• W2022361557 abstract "Although considerable attention has focused on obesity, insulin resistance and abnormal lipid metabolism as coronary risk factors, it remains unclear how these pathogenic factors affect the inflammatory response after myocardial ischemia-reperfusion. This study was conducted to evaluate whether these metabolic disorders exacerbate myocardial ischemia-reperfusion injury, and to determine if ischemia-reperfusion injury could be modified with the thiazolidinedione, pioglitazone. Experiments were performed in KK-A(y) and C57BL/6J mice subjected to 40 min of ischemia followed by reperfusion. Infiltration of inflammatory cells in ischemic myocardium, and infarct size 3 days after reperfusion were significantly higher in KK-A(y) than C57BL/6J mice (p<0.05 and p<0.001, respectively). Furthermore, expression of chemokines, inflammatory cytokines and extracellular matrix proteins in ischemic myocardium was significantly higher in KK-A(y) than C57BL/6J mice 1 day after reperfusion. Pioglitazone treatment of KK-A(y) mice for 14 days significantly reduced the accumulation of inflammatory cells in ischemic myocardium, and infarct size 3 days after reperfusion compared to vehicle treatment (p<0.05 and p<0.05, respectively). Pioglitazone also attenuated expression of chemokines, inflammatory cytokines and extracellular matrix proteins in ischemic myocardium 1 day after reperfusion. In vitro experiments demonstrated that tumor necrosis factor-alpha (TNF-alpha) was significantly higher in cultured peritoneal macrophages from KK-A(y) than C57BL/6J mice, and pioglitazone significantly reduced TNF-alpha in macrophages from both types of mice. These findings suggest that metabolic disorders exacerbate ischemia-reperfusion injury as a result of overexpression of inflammatory mediators, and this effect might be improved, in part by the anti-inflammatory effects of pioglitazone." @default.
• W2022361557 created "2016-06-24" @default.
• W2022361557 creator A5012158784 @default.
• W2022361557 creator A5015426068 @default.
• W2022361557 creator A5020090012 @default.
• W2022361557 creator A5020527263 @default.
• W2022361557 creator A5026409331 @default.
• W2022361557 creator A5060103549 @default.
• W2022361557 creator A5072409057 @default.
• W2022361557 creator A5075403819 @default.
• W2022361557 creator A5079485654 @default.
• W2022361557 creator A5087664973 @default.
• W2022361557 date "2008-05-01" @default.
• W2022361557 modified "2023-10-17" @default.
• W2022361557 title "Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia–reperfusion injury in mice with metabolic disorders" @default.
• W2022361557 cites W1587875569 @default.
• W2022361557 cites W1633340712 @default.
• W2022361557 cites W1639924204 @default.
• W2022361557 cites W1974182241 @default.
• W2022361557 cites W1978095098 @default.
• W2022361557 cites W1992545920 @default.
• W2022361557 cites W1997608954 @default.
• W2022361557 cites W1998228732 @default.
• W2022361557 cites W2000054651 @default.
• W2022361557 cites W2002519246 @default.
• W2022361557 cites W2005265409 @default.
• W2022361557 cites W2007194743 @default.
• W2022361557 cites W2007532611 @default.
• W2022361557 cites W2019235722 @default.
• W2022361557 cites W2020510386 @default.
• W2022361557 cites W2023097850 @default.
• W2022361557 cites W2023535950 @default.
• W2022361557 cites W2031681951 @default.
• W2022361557 cites W2039601697 @default.
• W2022361557 cites W2040200395 @default.
• W2022361557 cites W2050744280 @default.
• W2022361557 cites W2050767863 @default.
• W2022361557 cites W2055600725 @default.
• W2022361557 cites W2061448989 @default.
• W2022361557 cites W2080085786 @default.
• W2022361557 cites W2088499548 @default.
• W2022361557 cites W2093352910 @default.
• W2022361557 cites W2102772338 @default.
• W2022361557 cites W2105448220 @default.
• W2022361557 cites W2122681066 @default.
• W2022361557 cites W2124821727 @default.
• W2022361557 cites W2129316761 @default.
• W2022361557 cites W2135874575 @default.
• W2022361557 cites W2138201763 @default.
• W2022361557 cites W2145697808 @default.
• W2022361557 cites W2148571823 @default.
• W2022361557 cites W2154626866 @default.
• W2022361557 cites W2156280702 @default.
• W2022361557 cites W2168276527 @default.
• W2022361557 cites W2170831952 @default.
• W2022361557 cites W2171157803 @default.
• W2022361557 cites W2335895544 @default.
• W2022361557 doi "https://doi.org/10.1016/j.yjmcc.2008.03.004" @default.
• W2022361557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18436235" @default.
• W2022361557 hasPublicationYear "2008" @default.
• W2022361557 type Work @default.
• W2022361557 sameAs 2022361557 @default.
• W2022361557 citedByCount "39" @default.
• W2022361557 countsByYear W20223615572012 @default.
• W2022361557 countsByYear W20223615572013 @default.
• W2022361557 countsByYear W20223615572014 @default.
• W2022361557 countsByYear W20223615572015 @default.
• W2022361557 countsByYear W20223615572016 @default.
• W2022361557 countsByYear W20223615572017 @default.
• W2022361557 countsByYear W20223615572018 @default.
• W2022361557 countsByYear W20223615572020 @default.
• W2022361557 countsByYear W20223615572021 @default.
• W2022361557 countsByYear W20223615572022 @default.
• W2022361557 countsByYear W20223615572023 @default.
• W2022361557 crossrefType "journal-article" @default.
• W2022361557 hasAuthorship W2022361557A5012158784 @default.
• W2022361557 hasAuthorship W2022361557A5015426068 @default.
• W2022361557 hasAuthorship W2022361557A5020090012 @default.
• W2022361557 hasAuthorship W2022361557A5020527263 @default.
• W2022361557 hasAuthorship W2022361557A5026409331 @default.
• W2022361557 hasAuthorship W2022361557A5060103549 @default.
• W2022361557 hasAuthorship W2022361557A5072409057 @default.
• W2022361557 hasAuthorship W2022361557A5075403819 @default.
• W2022361557 hasAuthorship W2022361557A5079485654 @default.
• W2022361557 hasAuthorship W2022361557A5087664973 @default.
• W2022361557 hasConcept C126322002 @default.
• W2022361557 hasConcept C13373296 @default.
• W2022361557 hasConcept C134018914 @default.
• W2022361557 hasConcept C164027704 @default.
• W2022361557 hasConcept C170493617 @default.
• W2022361557 hasConcept C17991360 @default.
• W2022361557 hasConcept C2776914184 @default.
• W2022361557 hasConcept C2776923340 @default.
• W2022361557 hasConcept C2777180221 @default.
• W2022361557 hasConcept C2778384471 @default.
• W2022361557 hasConcept C2778938600 @default.
• W2022361557 hasConcept C2780114680 @default.
• W2022361557 hasConcept C541997718 @default.

• next